To explore an anti-fibrotic potency of PRS inhibitor-induced transcriptomes in an unbiased manner, we performed a comparison of gene expression between PRS inhibitor-induced common genes and fibroblast from scleroderma patients (GSE4385). This evidence concerns the gene WNK3 and scleroderma.